Trials / Sponsors / Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB Acute Myeloid Leukemia, Myelodysplasia | Phase 1 | 2022-02-14 |
| Terminated | A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell T Inherited Metabolic Disorders (IMD) | — | 2019-05-21 |
| Completed | MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HS Inherited Metabolic Disorders (IMD) | Phase 2 | 2018-02-09 |